IMU

5.56%

5.7¢ imugene limited

I agree with a most of that except for one point. When you say "...

First 834 Last

Share
Profile

Follow
lockstock79

1,169 Posts.

254

26/11/20

23:03

Post #: 49178445
Share

Originally posted by really stupid: ↑

For some of the newer folk expressing concern about the price swings - a few thoughts to calm the nerves.

When this hit 13c, it meant 10bags on my first purchase at 1.3c a few years back. Hooray for me - but that's not why I'm posting.

Back when I first got into it, IMU was simply a HER VAXX play. I liked the thesis and it's now borne some fruit. Hooray for IMU.

I still like HER VAXX and if that was all IMU was, I'd still be invested here.

The share price has gone up and down along the way - but the recent trial results significantly de-risk the company (in my view) and that cannot be over-emphasised from an investability point of view. We now really know that HER VAXX works - it's just a question of how well it plays across a deeper cohort. If it plays well, there is solid upside from here. (As folks regularly point out - Herceptin the current market leading HER2 receptor treatment is continuing to expand and has sales around USD7bn per year).

Back at 1.3c (and with less shares on issue), the market gave an almost zero probability that HER VAXX would succeed in any way. For me, that made it worth a punt. The market has now assigned some value to HER VAXX - which is nice. However, on the basis of the current market cap (USD400m), in my own view, they are valuing PD1 VAXX and CF33 at zero. IMU a safer bet at 10c than it was at 1.3c - but I reckon there is still another 10 bags in this baby yet and the punt is still on. I personally agree with what the CEO said about the VER VAXX trial results validating the whole IP suite. I think it does. And, I think we're undervalued here.

I'm certainly not selling. I want my full 100 bags. Been adding a bit on the way up - and as the trial results come in and IMU de-risks further, I'll add a bit more. If you're minded to do the same, you'll fine some great advice from some of the regular long-term chartists pointing out good entry/addition points along the way. You'll do well to take the benefit of what they say - as they have proved solid in the years I have been in IMU and on this board. Take the time to look at it and you'll work out who they are.

You've got to bear in mind that this has had a bit run up - and when that happens you do see pull backs - some folks are happy to take a quick earn and look for the next thing. However, if you like the IP, a sell off is not a wholly bad thing as you get a better entry/top up point.

Finally, as others have said: most importantly - we've all played a small role in helping some really sick people. That beats $$ any day.

Expand

I agree with a most of that except for one point. When you say " I personally agree with what the CEO said about the VER VAXX trial results validating the whole IP suite" that doesnt include CF33 as that is separate to the rest of our IP. I am guessing you know that, however thought I would just point it out as we have a lot of newbies on here these days. I too am waiting for my 100 bags

IMU Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

RCE

Recce's R327 found effective against E.coli during clinical trial

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

There are more pages in this discussion • 965 more messages in this thread...

First 834 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.7¢		Change 0.003(5.56%)		Mkt cap ! $417.2M

Open	High	Low	Value	Volume
5.5¢	5.8¢	5.2¢	$2.499M	45.00M

Buyers (Bids)

No.	Vol.	Price($)
2	1921794	5.6¢

Sellers (Offers)

Price($)	Vol.	No.
5.7¢	1368288	7

View Market Depth

No.	Vol.	Price($)
5	286362	0.055
9	2036888	0.054
16	2736044	0.053
20	1943436	0.052
23	3206056	0.051

Price($)	Vol.	No.
0.057	378902	2
0.058	1552127	7
0.059	837099	8
0.060	2176188	16
0.061	1163926	6

Last trade - 16.10pm 28/06/2024 (20 minute delay)

IMU (ASX) Chart

I agree with a most of that except for one point. When you say "...

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Recce's R327 found effective against E.coli during clinical trial

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I agree with a most of that except for one point. When you say "...

Top Stories

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Recce's R327 found effective against E.coli during clinical trial

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Microcap Wrap: 5 explorers with news out today

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Ava Risk Group expands US presence with A$0.7M Substation Deal

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News